How well do other non-F1M methods for NGS assessment work? Are they as effective? Highly aggressive or resistant tumors? Cancers of unknown primary? Cancers with limited tissue samples?

How well do other non-F1M methods for NGS assessment work? Are they as effective? Highly aggressive or resistant tumors? Cancers of unknown primary? Cancers with limited tissue samples?

How well do other non-F1M methods for NGS assessment work? Are they as effective? Why or why not? Highly aggressive or resistant tumors? Cancers of unknown primary? Cancers with limited tissue samples? Please explain.


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea